Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Amarc Enterprises, Inc.
WARNING LETTER
•Amarc Enterprises, Inc.

Amarc Enterprises, Inc. – FDA Warning Letter

Record Details

On December 11, 2012, the FDA issued a Warning Letter to Amarc Enterprises, Inc. concerning the marketing of their products, Poly-MVA and Poly-MVA for Pets. The FDA reviewed the firm's websites (www.polymva.com, www.polymva.net, www.polymva4pets.com, www.polymvaforpets.com) and product literature, including a book titled "Poly-MVA A New Supplement in the Fight Against Cancer" and a "Testimonials" document.

The FDA determined that Poly-MVA and Poly-MVA for Pets are promoted for conditions that cause them to be unapproved new drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)]. Claims, including numerous testimonials, suggest the products are intended for the cure, mitigation, treatment, or prevention of diseases such as various cancers, diabetes, Alzheimer's, heart disease, stroke, arthritis, psoriasis, and endometriosis in humans, and tumors, leukemia, lymphoma, and other cancers in animals.

These products are considered "new drugs" and "new animal drugs" because they are not generally recognized as safe and effective for their claimed uses. They lack prior FDA approval, which is required under section 5

Company
Amarc Enterprises, Inc.
Product type
Drugs
Office
Department of Health and Human Services
People
  • Alonza E. Cruse (Director)
  • Ingeborg Small
View Company Profile

ID · e4650c55-a44e-4821-8e71-bc4fe313b5a7

Violation Codes10
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 321(v)21 U.S.C. 360b21 U.S.C. 360ccc21 U.S.C. 360ccc-121 U.S.C. 360b(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amarc Enterprises, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.